Matches in SemOpenAlex for { <https://semopenalex.org/work/W4246976028> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4246976028 endingPage "8265" @default.
- W4246976028 startingPage "8265" @default.
- W4246976028 abstract "8265 Background: Lung cancer is extremely common and its cost for society is not extensively studied. ALCEA (Advanced Lung Cancer Economic Assessment) -an observational cost-of-illness study -has generated economic data on patients affected by NSCLC in an advanced stage, exploring both direct and indirect costs determined by this pathology in Italy. Methods: A total of 189 patients treated with first line chemotherapy (1st L), second line chemotherapy (2nd L) or supportive therapy (ST) were observed for a six-month period or until death. Direct costs were measured according to consumption of healthcare resources (hospitalisations, specialist visits, drugs, diagnostic tests and laboratory tests) and costed according to current Italian tariffs. A sample of total costs and an average per patient cost were produced and analysed for the 1st L, 2nd L and supportive therapy. Indirect costs were evaluated only in terms of reduced or lost productivity due to morbidity or mortality of patients. Results: In 1st and 2nd line treatments the highest direct costs were determined by hospitalisations due to chemotherapy -with a mean cost per patient of € 4,350 and € 2,417 respectively - and by hospitalisations due to adverse eventsother disease related reasons–€ 3,819 and € 5,108 respectively. For ST the highest costs were generated by hospitalisations occurred for reasons other than chemotherapy with a mean per patient cost of € 6,211. The productivity loss was estimated to be a total of 369 years, which means about €11,390,000 and an average per patient cost of € 60,263. Conclusions: ST may be a suggested strategy in the treatment of advanced NSCLC when chemotherapy appears to have a limited efficacy and worsening of patient performance status. The management of NSCLC imposes a considerable burden on society. Infact, it implies a high level of utilization of healthcare resources and a significant productivity loss, despite many patients have already retired at the time of first diagnosis. Author Disclosure Employment or Leadership Consultant or Advisory Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration AstraZeneca AstraZeneca AstraZeneca" @default.
- W4246976028 created "2022-05-12" @default.
- W4246976028 creator A5016217905 @default.
- W4246976028 creator A5036649295 @default.
- W4246976028 creator A5038701966 @default.
- W4246976028 creator A5061398039 @default.
- W4246976028 creator A5067409424 @default.
- W4246976028 creator A5081658451 @default.
- W4246976028 creator A5085341141 @default.
- W4246976028 date "2004-07-15" @default.
- W4246976028 modified "2023-09-27" @default.
- W4246976028 title "Cost of non-small cell lung cancer in Italy. Results of the longitudinal study ALCEA (Advanced Lung Cancer Economic Assessment)" @default.
- W4246976028 doi "https://doi.org/10.1200/jco.2004.22.14_suppl.8265" @default.
- W4246976028 hasPublicationYear "2004" @default.
- W4246976028 type Work @default.
- W4246976028 citedByCount "0" @default.
- W4246976028 crossrefType "journal-article" @default.
- W4246976028 hasAuthorship W4246976028A5016217905 @default.
- W4246976028 hasAuthorship W4246976028A5036649295 @default.
- W4246976028 hasAuthorship W4246976028A5038701966 @default.
- W4246976028 hasAuthorship W4246976028A5061398039 @default.
- W4246976028 hasAuthorship W4246976028A5067409424 @default.
- W4246976028 hasAuthorship W4246976028A5081658451 @default.
- W4246976028 hasAuthorship W4246976028A5085341141 @default.
- W4246976028 hasConcept C121608353 @default.
- W4246976028 hasConcept C121955636 @default.
- W4246976028 hasConcept C126322002 @default.
- W4246976028 hasConcept C139719470 @default.
- W4246976028 hasConcept C141071460 @default.
- W4246976028 hasConcept C144133560 @default.
- W4246976028 hasConcept C162324750 @default.
- W4246976028 hasConcept C175444787 @default.
- W4246976028 hasConcept C177713679 @default.
- W4246976028 hasConcept C182299520 @default.
- W4246976028 hasConcept C194828623 @default.
- W4246976028 hasConcept C204983608 @default.
- W4246976028 hasConcept C23131810 @default.
- W4246976028 hasConcept C2776256026 @default.
- W4246976028 hasConcept C2776694085 @default.
- W4246976028 hasConcept C6964187 @default.
- W4246976028 hasConcept C71924100 @default.
- W4246976028 hasConceptScore W4246976028C121608353 @default.
- W4246976028 hasConceptScore W4246976028C121955636 @default.
- W4246976028 hasConceptScore W4246976028C126322002 @default.
- W4246976028 hasConceptScore W4246976028C139719470 @default.
- W4246976028 hasConceptScore W4246976028C141071460 @default.
- W4246976028 hasConceptScore W4246976028C144133560 @default.
- W4246976028 hasConceptScore W4246976028C162324750 @default.
- W4246976028 hasConceptScore W4246976028C175444787 @default.
- W4246976028 hasConceptScore W4246976028C177713679 @default.
- W4246976028 hasConceptScore W4246976028C182299520 @default.
- W4246976028 hasConceptScore W4246976028C194828623 @default.
- W4246976028 hasConceptScore W4246976028C204983608 @default.
- W4246976028 hasConceptScore W4246976028C23131810 @default.
- W4246976028 hasConceptScore W4246976028C2776256026 @default.
- W4246976028 hasConceptScore W4246976028C2776694085 @default.
- W4246976028 hasConceptScore W4246976028C6964187 @default.
- W4246976028 hasConceptScore W4246976028C71924100 @default.
- W4246976028 hasIssue "14_suppl" @default.
- W4246976028 hasLocation W42469760281 @default.
- W4246976028 hasOpenAccess W4246976028 @default.
- W4246976028 hasPrimaryLocation W42469760281 @default.
- W4246976028 hasRelatedWork W1599998596 @default.
- W4246976028 hasRelatedWork W2083886967 @default.
- W4246976028 hasRelatedWork W2107272669 @default.
- W4246976028 hasRelatedWork W2410179502 @default.
- W4246976028 hasRelatedWork W2413872662 @default.
- W4246976028 hasRelatedWork W2613123537 @default.
- W4246976028 hasRelatedWork W2994897345 @default.
- W4246976028 hasRelatedWork W2995645931 @default.
- W4246976028 hasRelatedWork W3016751953 @default.
- W4246976028 hasRelatedWork W39734877 @default.
- W4246976028 hasVolume "22" @default.
- W4246976028 isParatext "false" @default.
- W4246976028 isRetracted "false" @default.
- W4246976028 workType "article" @default.